PF-Atlas › Drugs › Pirfenidone

Pirfenidone

Idiopathic Pulmonary Fibrosis

Clinical trials

Developer

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Overview

Pirfenidone is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 26 tracked IPF clinical trials.

Pirfenidone clinical trials

NCT00001959 (Phase 2)NCT00662038 (Phase 3)NCT02951429 (Phase 2)NCT00287729 (Phase 3)NCT01504334 (Phase 2)NCT02932566 (Phase 2)NCT00287716 (Phase 3)NCT05075161 (Phase 3)NCT03359863 (Phase 2)NCT02648048 (Phase 1)NCT03260556 (Phase 4)NCT04282902 (Phase 3)

Explore related

All trials Research

Medical disclaimer. This page summarizes research about Pirfenidone for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.